MIF-TNFRSF14 was differentially interacted both in SMM and MM (Figure 3E), whereas elevated expression of MIF, a pro-inflammatory cytokine (Alibashe-Ahmed et al., 2019) and an oncogene (Yao et al., 2021), was associated with stronger suppression of T-cell proliferation (Zhang et al., 2017). The gene discussed is MIF; the disease is Miyoshi myopathy.